NR
RMD icon

Newfound Research’s ResMed RMD Stock Holding History

Newfound Research’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$90K Sell
410
-57
-12% -$13K 0.22% 23
2022
Q2 		$98K Sell
467
-43
-8% -$9.15K 0.21% 39
2022
Q1 		$124K Buy
+510
New +$123K 0.16% 75
2021
Q4 		– Sell
-260
Closed -$69K – 135
2021
Q3 		$69K Sell
260
-136
-34% -$37.2K 0.11% 103
2021
Q2 		$98K Buy
396
+18
+5% +$3.78K 0.19% 17
2021
Q1 		$73K Sell
378
-20
-5% -$4.01K 0.17% 70
2020
Q4 		$85K Buy
398
+229
+136% +$45.7K 0.22% 89
2020
Q3 		$29K Buy
+169
New +$31.2K 0.08% 90

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Newfound Research's RMD Position: Q3 2022 in Review

Newfound Research reduced its ResMed (RMD) stake by 12% in Q3 2022, selling an estimated $13K and leaving 410 shares worth $90K. The position accounts for 0.22% of the portfolio, ranked #23.

Newfound Research first reported a position in RMD in Q3 2020 and has held it in 8 quarters since. The position peaked at $124K in Q1 2022. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Newfound Research held 410 shares of ResMed worth $90K as of Q3 2022.
  • Newfound Research sold 57 ResMed shares in Q3 2022, an estimated $13K.
  • ResMed made up 0.22% of Newfound Research's portfolio in Q3 2022, its #23 holding.
  • Newfound Research first reported a position in ResMed in Q3 2020 and has held it in 8 quarters since.
  • Newfound Research's ResMed position peaked at $124K in Q1 2022.
  • 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.